The company was formally established in the United States in 2007, and in 20 10, Demsell International Private Medical Group was established through acquisition and holding, which is responsible for the operation of the global market, integrating high-profile world-class R&D teams such as Harvard University, Stanford University, Oxford University, Cambridge University and University of Southern California, covering biotechnology, information technology, nanotechnology and other fields. Together with the world-class medical expert team and information expert team, through IPM's private medical management system, terminal tablet.

Due to the rapid development of emerging markets in Asia, the global headquarters decided to upgrade the original Hong Kong company to the Asia-Pacific headquarters, and Demsell (Hong Kong) International Private Medical Group was responsible for the operation and management of the Asia-Pacific region. Through acquisition and merger, the former Beijing company, namely Beijing Demsell Biotechnology, will be taken as the headquarters of Greater China and moved to "Outward SOHO" 2011in the CBD of Beijing. Beijing Demsell is responsible for the operation and management of Greater China, bringing the advanced management experience of IPM to China, bringing "IPM International Private Medical Customization Service" to China, and truly introducing private medical care, family medical care and leisure medical care to China, bringing a brand-new health management concept to people who have a high pursuit of high-quality life in China society.

IPM takes the patented technology and products independently developed as its core competitiveness, aiming at building a world-class professional system integrating anti-aging, treatment, diagnosis, prevention, rehabilitation and scientific research and development, realizing early diagnosis and treatment of major diseases, transforming major diseases from malignant and sudden intractable diseases into chronic and controllable diseases, improving patients' quality of life and prolonging patients' lives; Mr. Goldman, President of the International Association of Anti-aging Medicine, once said: "Aging is also a disease". IPM will also provide anti-aging treatment services for the majority of sub-healthy people in China through advanced stem cell anti-aging technology and medical technology; Through IPM's advanced stem cell plastic surgery technology and medical technology, we provide stem cell plastic surgery services for beauty seekers in China.

IPM has been and will always make unremitting efforts for the health and beauty of China people.

"IPM" is the only symbol of all service brands under IPM Group. All chain clubs, medical service institutions, educational service institutions and scientific research service institutions use the brand uniformly, and have applied for international trademark registration. Any unauthorized use is illegal.

"Damcell", as the only symbol of IPM Group's technology research and development brand, is protected by the laws of the United States and China.

Time Master, Time Secret Language, Time Magic and Time Miracle are the beauty brands in China market.

"eMed" is the brand of health management information system of IPM Group, including software system, health cloud network and tablet computer.

1, people with major diseases, such as cancer, diabetes, liver cirrhosis, stroke, etc.

2. Early intervention: such as early intervention and prevention of cancer;

3. Sub-healthy people affected by modern unhealthy lifestyles;

4. People with extremely high quality of life requirements;

5. People who have a high pursuit of external beauty and internal beauty.